C
Kiniksa Pharmaceuticals International, plc KNSA
$31.98 $1.725.68% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 108.83% 196.07% 29.98% -224.80% 77.93%
Total Depreciation and Amortization 3.77% -13.75% 0.25% -7.21% -7.73%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -2.32% 76.18% 50.90% -76.00% 46.72%
Change in Net Operating Assets -204.19% -92.21% 266.47% 156.55% -215.53%
Cash from Operations 25.83% 18.93% 939.45% -143.27% 29.62%
Capital Expenditure -66.67% 48.70% -- -- 100.00%
Sale of Property, Plant, and Equipment -- -- -- -100.00% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 92.77% -178.55% 1,131.60% 86.44% -282.84%
Cash from Investing 92.47% -178.94% 1,128.56% 86.44% -283.35%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 300.79% 16.91% -71.07% 728.28% -71.58%
Repurchase of Common Stock -396.84% 28.72% 78.69% -106.55% -244.62%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 286.49% 29.23% -67.98% 3,857.87% -104.93%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 231.97% -130.68% 4,649.08% 95.47% -226.21%